Topical corticosteroid addiction and withdrawal - An overview for GPs

Area of Science:

• Dermatology
• General Practice

Background:

• Topical corticosteroid (TCS) withdrawal, termed addiction, is a recognized complication of prolonged or inappropriate TCS use, particularly potent formulations on facial or genital areas.
• While discussed in media, TCS addiction and withdrawal remain underrepresented in medical literature.
• Australian General Practitioners (GPs) may encounter patients influenced by non-medical information regarding TCS withdrawal.

Purpose of the Study:

• To offer General Practitioners (GPs) a concise, evidence-based overview of topical corticosteroid (TCS) addiction and withdrawal.
• To equip GPs with knowledge to address patient concerns stemming from media discussions on TCS withdrawal.

Main Methods:

• Literature review and synthesis of current evidence on topical corticosteroid (TCS) addiction and withdrawal.
• Focus on clinical presentation, diagnosis, and management strategies relevant to general practice.

Main Results:

• Topical corticosteroids (TCS) are essential for managing conditions like eczema.
• Understanding TCS addiction and withdrawal is crucial for preventing adverse outcomes and providing patient support.
• GPs play a key role in clarifying misinformation and guiding patients through withdrawal.

Conclusions:

• Practitioners' awareness of TCS addiction and withdrawal aids in prevention and supportive care.
• GPs can effectively manage patients experiencing TCS withdrawal by providing evidence-based information and support.
• Empowering GPs to discuss TCS addiction and withdrawal fosters better patient outcomes and informed decision-making.